Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(60.0%)
Phase 1
2(40.0%)
5Total
N/A(3)
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07078006Not ApplicableCompleted

Injectable Platelet Rich Fibrin Versus Platelet Rich Plasma Injection in Degenerative Temporomandibular Joint

Role: lead

NCT06267326Phase 1Completed

World Health Organization (WHO) , COVID19 Case Series of Post Covid 19 Rhino Orbito Cerebral Mucormycosis in Egypt

Role: lead

NCT03492047Phase 1Completed

N-acetyl Cysteine Effect in Peripheral Neuropathy in Cancer Patients

Role: collaborator

NCT04151355Not ApplicableUnknown

Effect of Atorvastatin on 5-Fluorouracil Induced Mucositis

Role: collaborator

NCT03812419Not ApplicableCompleted

Esomeprazole or Pantoprazole in Renal Transplantation

Role: collaborator

All 5 trials loaded